A very low number of circulating basophils is predictive of a poor response to omalizumab in chronic spontaneous urticaria

Allergy. 2021 Apr;76(4):1254-1257. doi: 10.1111/all.14577. Epub 2020 Sep 17.

Authors

Matija Rijavec^{1

2}, Mitja Košnik^{1

3}, Ana Koren¹, Peter Kopač^{1

3}, Julij Šelb¹, Romana Vantur¹, Žan Kogovšek¹, Mojca Bizjak¹, Nissera Bajrović¹, Mihaela Zidarn^{1

3}, Peter Korošec¹

Affiliations

¹ University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
² Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
³ Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

PMID: 32876979
DOI: 10.1111/all.14577

No abstract available

Keywords: FcεRI; basophils; chronic spontaneous urticaria; gene expression; omalizumab.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Allergic Agents* / therapeutic use
Basophils
Chronic Disease
Chronic Urticaria*
Humans
Omalizumab / therapeutic use
Urticaria* / drug therapy

Substances

Anti-Allergic Agents
Omalizumab